Abstract
The use of cannabinoids for medicinal purposes has attracted wide interest in recent years, especially after the discovery of the endocannabinoid system. However, mechanisms relevant for neuroprotection and recovery of both exogenously applied and endogenous cannabinoids are only partly established. Supported by the observation that cannabinoids are released after neuronal injury and disorder, various CNS applications are currently investigated and both clinical and experimental data are now emerging. The present review describes possible mechanisms of cannabinoid actions relevant for neuroprotection, with a focus on excitotoxic cascades, oxidative stress and inflammation. The complexity of the system is outlined with regards to different cannabinoids, the receptors and cascades they activate, as well as the cell types and experimental approaches utilised to study their action. Furthermore, the unresolved problem of targeting protective pathways, while avoiding psychoactive and detrimental cascades is discussed.
Keywords: anandamide, excitotoxicity, inflammation, oxidative stress, transmitter release
Current Neuropharmacology
Title: Search and Rescue: Identification of Cannabinoid Actions Relevant for Neuronal Survival and Protection
Volume: 2 Issue: 1
Author(s): B. Platt and A. J. Drysdale
Affiliation:
Keywords: anandamide, excitotoxicity, inflammation, oxidative stress, transmitter release
Abstract: The use of cannabinoids for medicinal purposes has attracted wide interest in recent years, especially after the discovery of the endocannabinoid system. However, mechanisms relevant for neuroprotection and recovery of both exogenously applied and endogenous cannabinoids are only partly established. Supported by the observation that cannabinoids are released after neuronal injury and disorder, various CNS applications are currently investigated and both clinical and experimental data are now emerging. The present review describes possible mechanisms of cannabinoid actions relevant for neuroprotection, with a focus on excitotoxic cascades, oxidative stress and inflammation. The complexity of the system is outlined with regards to different cannabinoids, the receptors and cascades they activate, as well as the cell types and experimental approaches utilised to study their action. Furthermore, the unresolved problem of targeting protective pathways, while avoiding psychoactive and detrimental cascades is discussed.
Export Options
About this article
Cite this article as:
Platt B. and Drysdale J. A., Search and Rescue: Identification of Cannabinoid Actions Relevant for Neuronal Survival and Protection, Current Neuropharmacology 2004; 2 (1) . https://dx.doi.org/10.2174/1570159043476972
DOI https://dx.doi.org/10.2174/1570159043476972 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
The Role of microRNA in Ischemic and Hemorrhagic Stroke
Current Drug Delivery An Integrative Systems Analysis of High-grade Glioma Cell Lines: TLRs, Wnt, BRCA1, Netrins, STXBP1 and MDH1 Provide Putative Molecular Targets for Therapeutic Intervention
Current Pharmacogenomics and Personalized Medicine Polymer Drug Conjugates: Recent Advancements in Various Diseases
Current Pharmaceutical Design A Nanostructured Silica-Lipid Hybrid to Facilitate Oral SN-38-based Chemotherapy
Drug Delivery Letters The Role of Cetuximab and Other Epidermal Growth Factor Receptor Monoclonal Antibodies in the Treatment of Advanced Non-Small Cell Lung Cancer
Reviews on Recent Clinical Trials Targeting MDM4 as a Novel Therapeutic Approach for Hematologic Malignancies
Current Cancer Drug Targets Targeting SphK1 as a New Strategy against Cancer
Current Drug Targets Overview of Brain Tumor Stem Cells – Implications for Treatment
Current Signal Transduction Therapy Hemisynthesis of Selected Embelin Analogs and Investigation of their Proapoptotic Activity Against Cancer Cells
Medicinal Chemistry Gene Therapy Approaches for the Selective Killing of Cancer Cells
Current Pharmaceutical Design Expression of NRP-1 and NRP-2 in Endometrial Cancer
Current Pharmaceutical Biotechnology The Human L1 Element: A Potential Biomarker in Cancer Prognosis, Current Status and Future Directions
Current Molecular Medicine 2-Methoxyestradiol as a Potential Cytostatic Drug in Gliomas?
Anti-Cancer Agents in Medicinal Chemistry The Current Status of Novel PET Radio-Pharmaceuticals in Radiotherapy Treatment Planning of Glioma
Current Pharmaceutical Biotechnology Identification of 2-Fluoropalmitic Acid as a Potential Therapeutic Agent Against Glioblastoma
Current Pharmaceutical Design An Update of Radiolabeled Bombesin Analogs for Gastrin-Releasing Peptide Receptor Targeting
Current Pharmaceutical Design Radiolabeled RGD Peptides as Integrin alpha(v)beta3–targeted PET Tracers
Current Medicinal Chemistry AKT-pathway Inhibition in Chronic Lymphocytic Leukemia Reveals Response Relationships Defined by TCL1
Current Cancer Drug Targets The Roles of Histone Demethylase UTX and JMJD3 (KDM6B) in Cancers: Current Progress and Future Perspectives
Current Medicinal Chemistry Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors from the Natural Origin: A Recent Perspective
Anti-Cancer Agents in Medicinal Chemistry